Log Out Log Out

Nasal administration of BAQSIMI

BAQSIMI is absorbed via the intranasal route

Glucagon binds to and activates hepatic glucagon receptors.

This stimulates glycogen breakdown and release of glucose from the liver.

This in turn produces an antihypoglycemic effect.

Please note this link will take you to a website which is not part of LillyPro.ca.

Are you sure you want to
logout ?